Press releases

(French) ADN tumoral circulant dans le sang : un nouveau biomarqueur du cancer

Press release | 19 Jun 2012 - 16h36 | By INSERM PRESS OFFICE
Cancer

Sorry, this press release is only available in French.

TO CITE THIS POST :
Press release – Inserm press room (French) ADN tumoral circulant dans le sang : un nouveau biomarqueur du cancer Link : https://presse.inserm.fr/en/french-adn-tumoral-circulant-dans-le-sang-un-nouveau-biomarqueur-du-cancer/1831/

Other contents In the same category :

Cancer Voir tout

communi

New findings from analysis of malignant tumour progression

Researchers from Paris Descartes University, CNRS, Inserm, University Paris-Est Créteil (UPEC) and the Paris Public Hospitals (AP-HP) have shown that analysis of epigenetic modifications could be used as a universal marker for monitoring tumour DNA circulating in the bloodstream of patients with ...
communi

Two blood tests for predicting the efficacy of a lung cancer treatment

ALK gene rearrangement is observed in 4% of non-small-cell lung cancer (NSCLC) patients. Researchers from Gustave Roussy, Inserm and Université Paris-Sud, have shown that two blood samples can now predict the efficacy of treatment (crizotinib). These blood samples (taken before treatment initiation ...
fermer
fermer
RSS Youtube